If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Director/PDMR Shareholding

24 Oct 2019 14:30

RNS Number : 0641R
Reckitt Benckiser Group PLC
24 October 2019
 

 

24 October 2019

 

RECKITT BENCKISER GROUP PLC

 DIRECTOR/PDMR SHAREHOLDINGS

 

 

Reckitt Benckiser Group plc (the "Company" or "RB") announces the following change in the interests of a Director in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

 

The Company was notified on 23 October 2019 that Sara Mathew, Non-Executive Director, purchased a total of 378 American Depositary Receipts in the Company (ADRs) on 23 October 2019 at a price of $15.46 each. Five ADRs represent one Share.

 

The remuneration of RB's Non-Executive Directors includes fees which are to be used in the purchase of Shares or equivalent, e.g. ADRs. £16,750 of the Non-Executive Directors' base fee (net) is invested in Shares or equivalent which they are expected to retain for the duration of their tenure. The amount of Sara Mathew's fees applied in this way were pro-rated based on her appointment to the Board on 1 July 2019.  

 

 

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Sara Mathew

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

American Depositary Receipts (each American Depositary Receipt is equivalent to five Ordinary shares of 10 pence each in Reckitt Benckiser Group PLC)

GB00B24CGK77

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

$15.46

378

d)

Aggregated information

- Aggregated volume

- Price

 

Aggregate Price

Aggregate Volume

Aggregate Total

$15.46

378

$5843.88

 

e)

Date of the transaction

2019-10-23

f)

Place of the transaction

United States (OTC)

 

 

 

 

For further Information:Christine Logan

Deputy Company SecretaryTel +44 (0) 1753 217 800

 

Richard Joyce

SVP, Investor Relations

Tel. +44 (0)1753 217 800

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

About RB

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes.

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide.

For more information visit www.rb.com

 

 *RB is the trading name of the Reckitt Benckiser group of companies

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBXBDGRDDBGCS
Date   Source Headline
1st Dec 20179:00 amRNSTotal Voting Rights
8th Nov 20171:50 pmRNSDirector/PDMR Shareholding
7th Nov 20173:57 pmRNSHolding(s) in Company
2nd Nov 20177:00 amRNSDirector/PDMR Shareholding - Replacement
1st Nov 20175:52 pmRNSDirector/PDMR Shareholding
1st Nov 20179:00 amRNSTotal Voting Rights
18th Oct 20177:00 amRNSQ3 2017: Trading Update
6th Oct 20175:42 pmRNSDirector/PDMR Shareholding
3rd Oct 20174:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20179:50 amRNSHolding(s) in Company
2nd Oct 20173:46 pmRNSTotal Voting Rights
19th Sep 20177:00 amRNSDirectorate Change
14th Sep 20171:31 pmRNSHolding(s) in Company
4th Sep 20172:00 pmRNSDirector/PDMR Shareholding
1st Sep 20179:17 amRNSTotal Voting Rights
18th Aug 20177:00 amRNSCompletion of Sale of Food Business to McCormick
2nd Aug 201712:25 pmRNSDirector/PDMR Shareholding
1st Aug 20173:27 pmRNSTotal Voting Rights
24th Jul 20177:06 amRNSReckitt battles tough markets and disappointing Mead margins
24th Jul 20177:00 amRNSHalf-year Report
19th Jul 20177:00 amRNSRB Sale of Food Business to McCormick
6th Jul 20177:00 amRNSCyber attack update and estimated financial effect
3rd Jul 20179:29 amRNSTotal Voting Rights
23rd Jun 201711:00 amRNSPublication of a Prospectus - Replacement
22nd Jun 20175:26 pmRNSPublication of a Prospectus
22nd Jun 20174:19 pmRNSDirector/PDMR Shareholding
22nd Jun 201710:08 amRNSDirector/PDMR Shareholding
22nd Jun 20177:00 amRNSIssue of Debt
19th Jun 201711:47 amRNSDirector/PDMR Shareholding
15th Jun 20171:58 pmRNSCompletion of MJN Acquisition
12th Jun 20172:38 pmRNSExpected Completion Date of MJN Acquisition
1st Jun 20174:23 pmRNSDirector/PDMR Shareholding
1st Jun 201710:12 amRNSTotal Voting Rights
31st May 20174:58 pmRNSResult of General Meeting
31st May 20173:42 pmRNSDirector/PDMR Shareholding
26th May 20174:06 pmRNSDirector/PDMR Shareholding
22nd May 20172:44 pmRNSDirector/PDMR Shareholding
22nd May 20171:20 pmRNSDirector/PDMR Shareholding
16th May 20175:33 pmRNSDirector/PDMR Shareholding
16th May 20175:27 pmRNSDirector/PDMR Shareholding
12th May 20173:27 pmRNSDirector/PDMR Shareholding
8th May 20176:15 pmRNSDirector/PDMR Shareholding
5th May 20174:21 pmRNSCircular to Shareholders and Notice of GM
5th May 201712:07 pmRNSOutcome of Audit Tender
4th May 20176:16 pmRNSResult of AGM
2nd May 20179:00 amRNSTotal Voting Rights
21st Apr 20177:00 amRNSQ1 2017 : Trading Update
3rd Apr 20177:00 amRNSStrategic Review of Food Business
31st Mar 20174:45 pmRNSTotal Voting Rights
31st Mar 20179:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.